• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于数字乳腺断层合成的风险模型,以预测乳腺癌并指导临床护理。

A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care.

作者信息

Eriksson Mikael, Destounis Stamatia, Czene Kamila, Zeiberg Andrew, Day Robert, Conant Emily F, Schilling Kathy, Hall Per

机构信息

Department of Medical Epidemiology and Biostatistics, Karolinska institutet, SE-171 77 Stockholm, Sweden.

Elizabeth Wende Breast Care, Rochester, NY 14620, USA.

出版信息

Sci Transl Med. 2022 May 11;14(644):eabn3971. doi: 10.1126/scitranslmed.abn3971.

DOI:10.1126/scitranslmed.abn3971
PMID:35544593
Abstract

Screening with digital breast tomosynthesis (DBT) improves breast cancer detection and reduces false positives. However, currently, no breast cancer risk model takes advantage of the additional information generated by DBT imaging for breast cancer risk prediction. We developed and internally validated a DBT-based short-term risk model for predicting future late-stage and interval breast cancers after negative screening exams. We included the available 805 incident breast cancers and a random sample of 5173 healthy women matched on year of study entry in a nested case-control study from 154,200 multiethnic women, aged 35 to 74, attending DBT screening in the United States between 2014 and 2019. A relative risk model was trained using elastic net logistic regression and nested cross-validation to estimate risks for using imaging features and age. An absolute risk model was developed using derived risks and U.S. incidence and competing mortality rates. Absolute risks, discrimination performance, and risk stratification were estimated in the left-out validation set. The discrimination performance of 1-year risk was 0.82 (95% CI, 0.79 to 0.85) with good calibration ( = 0.7). Using the U.S. Preventive Service Task Force guidelines, 14% of the women were at high risk, 19.6 times higher compared to general risk. In this high-risk group, 76% of stage II and III cancers and 59% of stage 0 cancers were observed ( < 0.01). Using mammographic features generated from DBT screens, our image-based risk prediction model could guide radiologists in selecting women for clinical care, potentially leading to earlier detection and improved prognoses.

摘要

数字乳腺断层合成(DBT)筛查可提高乳腺癌检测率并减少假阳性。然而,目前尚无乳腺癌风险模型利用DBT成像产生的额外信息进行乳腺癌风险预测。我们开发并在内部验证了一种基于DBT的短期风险模型,用于预测筛查结果为阴性后的未来晚期和间期乳腺癌。在一项巢式病例对照研究中,我们纳入了来自154,200名年龄在35至74岁之间、2014年至2019年在美国接受DBT筛查的多民族女性中的805例新发乳腺癌病例以及在研究入组年份匹配的5173名健康女性的随机样本。使用弹性网逻辑回归和嵌套交叉验证训练相对风险模型,以估计利用影像特征和年龄的风险。使用推导风险以及美国发病率和竞争死亡率建立绝对风险模型。在留出的验证集中估计绝对风险、鉴别性能和风险分层。1年风险的鉴别性能为0.82(95%CI,0.79至0.85),校准良好( = 0.7)。根据美国预防服务工作组指南,14%的女性处于高风险状态,是一般风险女性的19.6倍。在这个高风险组中,观察到76%的II期和III期癌症以及59%的0期癌症( < 0.01)。利用DBT筛查产生的乳腺X线特征,我们基于图像的风险预测模型可以指导放射科医生选择需要临床护理的女性患者,有可能实现更早的检测并改善预后。

相似文献

1
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care.一种用于数字乳腺断层合成的风险模型,以预测乳腺癌并指导临床护理。
Sci Transl Med. 2022 May 11;14(644):eabn3971. doi: 10.1126/scitranslmed.abn3971.
2
3
False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis.数字乳腺断层合成摄影与常规乳腺 X 线摄影筛查乳腺癌的假阴性率比较。
Radiology. 2021 Feb;298(2):296-305. doi: 10.1148/radiol.2020202858. Epub 2020 Dec 1.
4
Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.数字乳腺 X 线摄影与数字乳腺断层合成技术对乳腺癌幸存者的影像学监测比较。
Radiology. 2021 Feb;298(2):308-316. doi: 10.1148/radiol.2020201854. Epub 2020 Dec 22.
5
Community-Based Breast Cancer Screening Using Digital Breast Tomosynthesis Versus Digital Mammography: Comparison of Screening Performance and Tumor Characteristics.基于社区的数字化乳腺断层合成摄影与数字化乳腺钼靶摄影筛查乳腺癌的比较:筛查性能和肿瘤特征比较。
AJR Am J Roentgenol. 2022 Feb;218(2):249-257. doi: 10.2214/AJR.21.26384. Epub 2021 Sep 15.
6
Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.连续 5 年使用数字乳腺断层合成技术进行筛查:按筛查年度和轮次的结果。
Radiology. 2020 May;295(2):285-293. doi: 10.1148/radiol.2020191751. Epub 2020 Mar 10.
7
8
Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.数字乳腺断层合成摄影术与数字乳腺 X 线摄影术对年龄和乳腺密度相关的癌症检出率和召回率的比较。
JAMA Oncol. 2019 May 1;5(5):635-642. doi: 10.1001/jamaoncol.2018.7078.
9
Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.数字乳腺 X 线摄影与数字乳腺 X 线摄影加断层合成在乳腺癌筛查中的比较:奥斯陆断层合成筛查试验。
Radiology. 2019 Apr;291(1):23-30. doi: 10.1148/radiol.2019182394. Epub 2019 Feb 19.
10
Screening Mammography Performance Metrics of 2D Digital Mammography Versus Digital Breast Tomosynthesis in Women With a Personal History of Breast Cancer.乳腺癌病史女性的 2D 数字乳腺钼靶与数字乳腺断层合成筛查性能指标比较。
AJR Am J Roentgenol. 2021 Sep;217(3):587-594. doi: 10.2214/AJR.20.23976. Epub 2020 Sep 23.

引用本文的文献

1
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.在WISDOM研究中大规模整合乳腺癌多基因风险评分:一项全国性随机个性化筛查试验
Genome Med. 2025 Aug 28;17(1):97. doi: 10.1186/s13073-025-01524-7.
2
Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis.女性乳腺癌发病风险预测模型的开发与性能:一项系统评价和荟萃分析。
Ann Med. 2025 Dec;57(1):2534522. doi: 10.1080/07853890.2025.2534522. Epub 2025 Jul 20.
3
Deep Learning in Digital Breast Tomosynthesis: Current Status, Challenges, and Future Trends.
数字乳腺断层合成中的深度学习:现状、挑战与未来趋势。
MedComm (2020). 2025 Jun 9;6(6):e70247. doi: 10.1002/mco2.70247. eCollection 2025 Jun.
4
Deriving a Mammogram-Based Risk Score from Screening Digital Breast Tomosynthesis for 5-Year Breast Cancer Risk Prediction.从筛查数字乳腺断层合成中得出基于乳房X光检查的风险评分以预测5年乳腺癌风险
Cancer Prev Res (Phila). 2025 Jun 2;18(6):347-354. doi: 10.1158/1940-6207.CAPR-24-0427.
5
A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women's health.通过重新思考我们对待女性健康的方式来降低乳腺癌发病率和死亡率的路线图。
Breast Cancer Res Treat. 2025 Jan;209(1):1-14. doi: 10.1007/s10549-024-07522-4. Epub 2024 Nov 12.
6
Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models.Wasm-iCARE:一个用于构建、验证和应用绝对风险模型的便携式且保护隐私的网络模块。
JAMIA Open. 2024 Jun 27;7(2):ooae055. doi: 10.1093/jamiaopen/ooae055. eCollection 2024 Jul.
7
Artificial Intelligence-Powered Imaging Biomarker Based on Mammography for Breast Cancer Risk Prediction.基于乳腺X线摄影的人工智能成像生物标志物用于乳腺癌风险预测。
Diagnostics (Basel). 2024 Jun 7;14(12):1212. doi: 10.3390/diagnostics14121212.
8
Breast cancer risk prediction using machine learning: a systematic review.使用机器学习进行乳腺癌风险预测:一项系统综述。
Front Oncol. 2024 Mar 20;14:1343627. doi: 10.3389/fonc.2024.1343627. eCollection 2024.
9
European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening-a nested case-control study.基于图像的人工智能短期风险模型用于个体化乳腺癌筛查的欧洲验证——一项巢式病例对照研究
Lancet Reg Health Eur. 2023 Dec 6;37:100798. doi: 10.1016/j.lanepe.2023.100798. eCollection 2024 Feb.
10
Breast density analysis of digital breast tomosynthesis.数字乳腺断层合成的乳腺密度分析。
Sci Rep. 2023 Oct 31;13(1):18760. doi: 10.1038/s41598-023-45402-x.